Vitamin D can modulate the innate and adaptive immune responses through a complex network. Our results revealed that serum levels of IL-12 and IFN-γ were significantly lower in the VitD3-deficient group in comparison to the control group, but no significant differences were observed in other cytokines, including IL-6, IL-10, and IL-17. Our results suggest that VitD3 deficiency in female students may result in defective immune system function and inability to produce adequate rates of important cytokines such as IL-12 and IFN-γ, the main cellular immunity cytokines [8, 21]. Therefore, it could be concluded that, VitD3-deficient individuals may be at risk of infection and many other disorders, due to defect in immune function following decline in the inflammatory cytokines.
Obviously, IL-12 and IFN-γ are important cytokines, which connect innate and acquired immunity [22]. Hence, it may be concluded that decreased IL-12 and IFN-γ cytokines in female students may result in inadequate cellular immune responses.
Adorini et al., showed that the administration of 1,25-(OH)2 D3 in patients with multiple sclerosis (MS) and controls significantly inhibited IL-17 production in both groups, but had no effect on IL-4 production. Moreover, VitD3 receptor agonists directly inhibit Th1 cytokines such as IL-2 and IFN-γ [23]. Deluca et al., [24] determined the mRNA levels that encode cytokines in the lymph node lymphocytes of control mice and those treated with 1,25-(OH)2D3. They found that VitD3 administration markedly increased TGF-ß1 and IL-4 mRNA levels, while there was a decrease in IFN-γ and TNF-α expression.
Correale et al., evaluated the effect of VitD3 on cytokine productions by T cells using purified CD4+ T cells [25]. The results demonstrated that VitD3 administration resulted in high numbers of IL-10 producing T cells and low numbers of IL-6 and IL-17 producing cells, whereas no changes were found in the number of T cells producing IL-4 or IFN-γ. They also showed that the combination of VitD3 and IL-10 resulted in elevated numbers of human IL-10 producing T cells compared to the impacts of VitD3. However, the study by Correale et al., were performed on the cells separated from MS patients in the in vitro condition, while in the present study, the correlations between VitD3 and serum levels of the cytokines were performed in the in vivo condition. Therefore, no significant difference in the amount of IL-10 between the VitD3-deficient and control groups may be related to its in vivo conditions, which needs more investigations. The reason for this discrepancy remains to be explained.
VitD3 inhibits the differentiation of monocytes into dendritic cells, and suppresses IL-12 secretion in vitro. Treatment of dendritic cells with VitD3 down-regulates the expression of co-stimulatory molecules and reduces IL-12 production [26]. Our result showed that the serum levels of IL-12 were significantly lower in the VitD3-deficient group compared to control group. Therefore, the decreased in the levels of IL-12 and IFN-γ in the VitD3-deficient group supports the importance of the regulatory role of VitD3 in the immune system.
As mentioned previously, the relation between VitD3 serum levels and cytokine production is controversial in several investigations. For instance, it has been reported that supplementation of VitD3 or 25(OH)D3 decreases IL-12 [27]. In agreement with the study, Barker and colleagues demonstrated that the serum concentrations of IFN-γ are significantly higher in vitamin D-deficient group compared to vitamin D-sufficient group [28]. The results are in contrast with our results which showed that serum levels of IL-12 and IFN-γ decreased in the VitD3-deficient group. It may be hypothesized that gender could be considered as a main interference factor in the investigations regarding the roles of VitD3 on the cytokine production because all of the subjects in our study were female, while the investigations by Barker et al., and Bischoff-Ferrari et al., were performed on both male and female subjects. Additionally, various ethnics and genetics could be considered as interference factors, which may affect cytokine productions [29]. However, there are some investigations which are in agreement with our results. For example, Barker et al., reported that supplementation of the vitamin D increased IFN-γ in vitamin D deficient individuals [30]. Interestingly, several studies demonstrated that vitamin D has immunomodulatory effects on the expression of pro-inflammatory cytokines such as IL-12, IL-18, TNF-α and IFN-γ during human pro-inflammatory based diseases [31–33]. Based on the fact that our participants were healthy female students, it seems that vitamin D has controversial functions due to the in vivo condition.
Additionally, although IL-17A has antagonist effects with IFN-γ and IL-12 [34], it is produced in response to fungi and bacterial infections and also participates in the pathophysiology of autoimmune diseases [35]. Therefore, it may be hypothesized that IL-17A have not been down-regulated in the VitD3-deficient group because of antagonist effects with IFN-γ and IL-12, as down-regulation of IFN-γ and IL-12 leads to up-regulation of IL-17A. Furthermore, due to the fact that cytokines/chemokines show their functions in a networked manner [36], IL-17A may try to retrieve the immunodeficiency following decreased expression of IFN-γ and IL-12 in the VitD3-deficient group.
Our results also demonstrated that there is no relation between age, weight, BMI, waist, hip, sun exposure and length with serum levels of IL-6, IL-10, IL-12, IL-17, and IFN-γ in the participants. Thus, it may be concluded that production of the cytokines is not associated with secretion of the pro/anti-inflammatory cytokines in our population (female students). Our previous investigations also confirmed the results and demonstrated that there is no association between the parameters like age, diet and so on with serum levels of IL-6, IL-10, IL-12, IL-17, and IFN-γ in the female students [18].